FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Syndicate content

Merck related Press Releases

Merck Statement in Response to FDA's June Communication with Updated Information on Leukotriene Inhibitors, Including Singulair

Posted June 15, 2009

Merck Statement in Response to the FDA's June 12, 2009 Communication with Updated Information on Leukotriene Inhibitors, Including SINGULAIR® (montelukast sodium) WHITEHOUSE STATION,... Read more...

Neuromed Pharmaceuticals Announces that Merck Terminates Research Collaboration and License Agreement

Posted June 11, 2009

Neuromed Pharmaceuticals Announces that Merck Terminates Research Collaboration and License Agreement for Compounds Targeting N-Type Calcium Channels CONSHOHOCKEN, PA and VANCOUVER, BC, June 11... Read more...

Xenon Enters Cardiovascular Disease Collaboration With Merck & Co., Inc.

Posted June 11, 2009

Xenon Enters Cardiovascular Disease Collaboration With Merck & Co., Inc. VANCOUVER, Canada, June 11 /PRNewswire/ -- Xenon today announced a strategic alliance with Merck & Co., Inc.,... Read more...

Merck to Launch TREDAPTIVETM (ER niacin/laropiprant) in International Markets Later This Year

Posted May 19, 2009

Merck to Launch TREDAPTIVETM (ER niacin/laropiprant) in International Markets Later This Year WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co., Inc. will begin launching TREDAPTIVETM (ER... Read more...

Studies of GARDASIL, Merck's Cervical Cancer Vaccine, and HPV 16 Vaccine Component of GARDASIL Presented at Conference

Posted May 11, 2009

Studies of GARDASIL, Merck's Cervical Cancer Vaccine, and HPV 16 Vaccine Component of GARDASIL Presented at International Papillomavirus Conference

Data from an Extension of a Phase II Study

... Read more...

Merck Engages PharmaVentures to Assist in the Divestment of its Italian Research Centre IRBM

Posted April 24, 2009

Merck Engages PharmaVentures to Assist in the Divestment of its Italian Research Centre IRBM OXFORD, England, April 24 /PRNewswire/ -- PharmaVentures Ltd, announced today that it has been engaged

... Read more...

Merck Announces Interim Phase IIa Study Results of MK-7009, an Investigational Oral Hepatitis C Virus Protease Inhibitor

Posted April 24, 2009

Merck Announces Interim Phase IIa Study Results of MK-7009, an Investigational Oral Hepatitis C Virus Protease Inhibitor, in Patients with Chronic Hepatitis C

Phase IIb Trial will Further

... Read more...

Merck & Co., Inc. and Santen Sign Licensing Agreement In Ophthalmology

Posted April 15, 2009

Merck & Co., Inc. and Santen Sign Licensing Agreement In Ophthalmology WHITEHOUSE STATION, N.J. - (Business Wire) Merck & Co., Inc. and Santen Pharmaceutical Co., Ltd. today announced a

... Read more...

Merck Provides Update on Merger Financing

Posted March 24, 2009

Merck Provides Update on Merger Financing

WHITEHOUSE STATION, N.J., March 23, 2009 - Merck & Co., Inc. today provided an update on the status of credit facilities that will be used to

... Read more...

Merck & Co., Inc. Provides Update on Previously-Disclosed U.S. Department of Justice Investigation Relating to VIOXX®

Posted March 24, 2009

Merck & Co., Inc. Provides Update on Previously-Disclosed U.S. Department of Justice Investigation Relating to VIOXX®

WHITEHOUSE STATION, N.J., March 23, 2009 - Merck & Co., Inc.

... Read more...